Mar 12, 2026

Development of High-Purity and High-Bioavailability Lycopene, and Launch of Sample Distribution

Product / Tech

Sustainability

Feb 19, 2026

(Update on Disclosed Matter) Regarding the policy to sell shares of SunPine AB

(207K)

IR

Feb 16, 2026

Regarding the policy to sell shares of SunPine AB

(350K)

IR

Feb 13, 2026

Notice Regarding Occurrence of a Ransomware Incident at Our U.S. Subsidiaries

Other

Jan 30, 2026

Consolidated Financial Results Highlights for the Third Quarter of the Fiscal Year ending March 31, 2026

(379K)

IR

Jan 30, 2026

Consolidated Financial Results Highlights 3Q 2025 (fiscal year ended March 31, 2026)

(552K)

IR